Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

New approaches to BRCA1 mutation detection.

J G Hacia1, L C Brody, F S Collins

  • 1National Human Genome Research Institute, Building 49/3A14, National Institutes of Health, Bethesda, MD 20892, USA.

Breast Disease
|February 3, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Genome Wide Conditional Mouse Knockout Resources.

Drug discovery today. Disease models·2024
Same author

FaceBase: A Community-Driven Hub for Data-Intensive Research.

Journal of dental research·2022
Same author

Genome-wide studies of von Willebrand factor propeptide identify loci contributing to variation in propeptide levels and von Willebrand factor clearance.

Journal of thrombosis and haemostasis : JTH·2016
Same author

Cellular characterisation of the GCKR P446L variant associated with type 2 diabetes risk.

Diabetologia·2011
Same author

Analysis of yeast artificial chromosome clones.

Methods in molecular biology (Clifton, N.J.)·2011
Same author

A role for coding functional variants in HNF4A in type 2 diabetes susceptibility.

Diabetologia·2010
Same journal

Paget disease of the breast: An often-overlooked malignancy.

Breast disease·2026
Same journal

Retrospective analysis of survival of patients with HER2-positive breast cancer with microscopic residual invasive disease after neoadjuvant chemotherapy.

Breast disease·2025
Same journal

Association between AKT1 polymorphisms and susceptibility to breast cancer in the Iranian population.

Breast disease·2025
Same journal

Circulating tumor cells as a clinical, diagnostic, and prognostic biomarker in breast cancer.

Breast disease·2025
Same journal

Isolated breast myeloid sarcoma: A diagnostic and therapeutic challenge. A case report and literature review.

Breast disease·2025
Same journal

Imaging evaluation of nipple discharge: Review of literature and management considerations.

Breast disease·2025
See all related articles

Future medical genetics relies on rapid, cost-effective mutation detection technologies. Innovations, like DNA chips for BRCA1 analysis, promise increased throughput and reduced costs for identifying genetic variants.

Area of Science:

  • Medical Genetics
  • Molecular Biology
  • Bioinformatics

Background:

  • Accurate identification of heterozygous mutations and sequence variants is essential for medical genetics.
  • Current mutation detection protocols require refinement for increased efficiency and reduced cost.
  • The allelic heterogeneity of BRCA1 mutations presents a significant challenge for comprehensive diagnostic testing.

Purpose of the Study:

  • To review recent technological advancements in mutation detection.
  • To highlight methodologies adaptable for BRCA1 mutation analysis.
  • To emphasize the potential of high-density oligonucleotide arrays (DNA chips) for sequence variation detection.

Main Methods:

  • Review of innovative methodologies for mutation detection.

Related Experiment Videos

  • Adaptation of existing and emerging techniques for BRCA1 gene analysis.
  • Focus on high-density oligonucleotide arrays (DNA chips) for sequence variation identification.

    • Main Results:

    • Emerging technologies offer potential for increased sample throughput.
    • New methods aim to decrease the cost of mutational analysis.
    • DNA chips show promise for efficient detection of BRCA1 sequence variations.

    Conclusions:

    • Technological advancements are crucial for the future of medical genetics.
    • Innovative methods, particularly DNA chips, can address challenges in analyzing large genes like BRCA1.
    • Faster, cheaper, and more comprehensive genetic variant detection is becoming increasingly feasible.